Neurological3 residues

Pinealon

Glu-Asp-Arg · EDR

Pinealon is the Glu-Asp-Arg tripeptide investigated in experimental oxidative-stress models. Its EDR sequence is different from the AEDG sequence of Epitalon.

Reviewed September 2026

Residues
3. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
Average mass
418.40 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
pI
4.37 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.

Primary structure

Sequence

N-terminusC-terminus
Glutamic acidGlu · EOpen amino-acid reference

Peptide. Sequence describes the reference peptide, not a tested supplier lot.

Calculated properties

Calculated from the sequence
FormulaC15H26N6O8
Monoisotopic mass418.1812 Da
Extinction coefficient at 280 nmNone (no Tyr or Trp)
A280 at 1 mg/mLNot measurable
Residues3
Average mass418.40 Da
pI4.37 (theoretical)
Identity
AliasesGlu-Asp-Arg, EDR
SequenceEDR
Research areaNeurological

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.

  • Residues: 3 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
  • Average mass: 418.40 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
  • pI: 4.37 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2

Residue composition

Unique residues
3
Most common
Glutamic acid
Nonpolar residues
0
Other classified residues
3

Glutamic acid is the most common residue (1). The calculated charge at pH 7 is net negative (-1.01).

Reference scope and linked records

Reference type: Peptide.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: Pinealon. The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. Pinealon, cell viability and free-radical levels. Source for the chemistry or study context discussed above; not an Aminos lot certificate.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About Pinealon

Identity and context

The primary study explicitly identifies the synthetic tripeptide as Glu-Asp-Arg. Similar names and overlapping research themes should not obscure that chemical difference. This entry describes the peptide identity rather than a heterogeneous pineal extract.

Reference classification

Peptide. The linked catalogue product is Pinealon. This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Match the EDR sequence and terminal chemistry to the analytical report. If an experiment depends on a particular stress model, document that model rather than describing an unqualified antioxidant effect.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesThe investigators tested several cell systems, including cerebellar granule cells, neutrophils and PC12 cells. They reported changes in reactive oxygen species accumulation, cell viability and signalling-related measurements under induced oxidative stress.Source context
What cannot be inferredThese are cell-model findings. They do not establish improved memory, neurological recovery or longevity in humans, and they do not show that a preparation is safe merely because the peptide is short.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. Pinealon, cell viability and free-radical levelsPrimary source for the reference discussion; not lot-specific product evidence.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.